Log In Sign up
The largest database of trusted experimental protocols

Xgen universal blocking oligonucleotides

Manufactured by Integrated DNA Technologies
Visit Supplier

XGen Universal Blocking oligonucleotides are synthetic DNA sequences designed to prevent non-specific binding during various molecular biology applications. They are compatible with a wide range of platforms and can be utilized to enhance the specificity of target detection or enrichment.

Automatically generated - may contain errors

Lab products found in correlation

Library amplification readymix containing kapa hifi dna polymerase, by Roche (3 mentions) Agilent bioanalyzer 2100 dna chip 7500, by Agilent Technologies (3 mentions) Human cot 1 dna, by Integrated DNA Technologies (1 mentions) Bioanalyzer 2100 dna chip 7500, by Agilent Technologies (1 mentions)

Close spelling variants of this product

Oligonucleotides

4 protocols using xgen universal blocking oligonucleotides

1

Targeted Enrichment of Clinically Relevant Genes

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
The FFPE and Non-FFPE samples were pooled separately using 500 ng of library for each sample. These two pools of libraries were then hybridized in solution to the HGSC VCRome 2.1 design (Bainbridge et al, 2011 (link)) (42 Mb [mega base]; NimbleGen) according to the manufacturer’s protocol NimbleGen SeqCap EZ Exome Library SR User’s Guide (Version 2.2) with minor revisions. For ∼3,500 clinically relevant genes that had low coverage (<20× coverage at ∼2.72 Mb sequencing data) probes were supplemented with PKv1 and PKv2 reagent spiked into the VCRome 2.1. Human COT1 DNA and xGen Universal Blocking oligonucleotides (Integrated DNA Technologies) were added into the hybridization to block repetitive genomic sequences and the adaptor sequences and hybridization was carried out at 42°C for 72 h. Post-capture LM-PCR amplification was performed using the Library Amplification Readymix containing KAPA HiFi DNA Polymerase (Cat no. KK2612; Kapa Biosystems, Inc.) with 12 cycles of amplification. After the final AMPure XP bead purification, quantity and size of the capture library was analyzed using the Agilent Bioanalyzer 2100 DNA Chip 7500.
Gingras M.C., Sabo A., Cardenas M., Rana A., Dhingra S., Meng Q., Hu J., Muzny D.M., Doddapaneni H., Perez L., Korchina V., Nessner C., Liu X., Chao H., Goss J, & Gibbs R.A. (2021). Sequencing of a central nervous system tumor demonstrates cancer transmission in an organ transplant. Life Science Alliance, 4(9), e202000941.
+ Open protocol
+ Expand
2

Exome Capture Library Preparation for Sequencing

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
Four pre-capture libraries were pooled together (~750 ng/sample, 3 ug/pool) and then hybridized in solution to the HGSC VCRome 2.1 design1 (Bainbridge et al., 2011 (link)) according to the manufacturer’s protocol NimbleGen SeqCap EZ Exome Library SR User’s Guide (Version 2.2) with minor revisions. Probes for exome coverage across > 3,500 clinically relevant genes that are previously < 20X (~2.72Mb) is supplemented into the VCRome 2.1 probe. Human COT1 DNA was added into the hybridization to block repetitive genomic sequences. Blocking oligonucleotides from Sigma (individually sequence specifically synthesized) or xGen Universal Blocking oligonucleotides (Integrated DNA Technologies) were added into the hybridization to block the adaptor sequences. Hybridization was carried out at 560C for ~16h. Post-capture LM-PCR amplification was performed using the Library Amplification Readymix containing KAPA HiFi DNA Polymerase (Kapa Biosystems, Inc.) with 12 cycles of amplification. After the final AMPure XP bead purification, quantity and size of the capture library was analyzed using the Agilent Bioanalyzer 2100 DNA Chip 7500. The efficiency of the capture was evaluated by performing a qPCR-based quality check on the four standard NimbleGen internal controls. Successful enrichment of the capture libraries was estimated to range from a 6 to 9 of ΔCT value over the non-enriched samples.
Rokita J.L., Rathi K.S., Cardenas M.F., Upton K.A., Jayaseelan J., Cross K.L., Pfeil J., Egolf L.E., Way G.P., Farrel A., Kendsersky N.M., Patel K., Gaonkar K.S., Modi A., Berko E.R., Lopez G., Vaksman Z., Mayoh C., Nance J., McCoy K., Haber M., Evans K., McCalmont H., Bendak K., Böhm J.W., Marshall G.M., Tyrrell V., Kalletla K., Braun F.K., Qi L., Du Y., Zhang H., Lindsay H.B., Zhao S., Shu J., Baxter P., Morton C., Kurmashev D., Zheng S., Chen Y., Bowen J., Bryan A.C., Leraas K.M., Coppens S.E., Doddapaneni H., Momin Z., Zhang W., Sacks G.I., Hart L.S., Krytska K., Mosse Y.P., Gatto G.J., Sanchez Y., Greene C.S., Diskin S.J., Vaske O.M., Haussler D., Gastier-Foster J.M., E. Anders K., Gorlick R., Li X.N., Reynolds C.P., Kurmasheva R.T., Houghton P.J., Smith M.A., Lock R.B., Raman P., Wheeler D.A, & Maris J.M. (2019). Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. Cell reports, 29(6), 1675-1689.e9.
+ Open protocol
+ Expand
3

Exome Capture Library Preparation for Sequencing

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
Four pre-capture libraries were pooled together (~750 ng/sample, 3 ug/pool) and then hybridized in solution to the HGSC VCRome 2.1 design1 (Bainbridge et al., 2011 (link)) according to the manufacturer’s protocol NimbleGen SeqCap EZ Exome Library SR User’s Guide (Version 2.2) with minor revisions. Probes for exome coverage across > 3,500 clinically relevant genes that are previously < 20X (~2.72Mb) is supplemented into the VCRome 2.1 probe. Human COT1 DNA was added into the hybridization to block repetitive genomic sequences. Blocking oligonucleotides from Sigma (individually sequence specifically synthesized) or xGen Universal Blocking oligonucleotides (Integrated DNA Technologies) were added into the hybridization to block the adaptor sequences. Hybridization was carried out at 560C for ~16h. Post-capture LM-PCR amplification was performed using the Library Amplification Readymix containing KAPA HiFi DNA Polymerase (Kapa Biosystems, Inc.) with 12 cycles of amplification. After the final AMPure XP bead purification, quantity and size of the capture library was analyzed using the Agilent Bioanalyzer 2100 DNA Chip 7500. The efficiency of the capture was evaluated by performing a qPCR-based quality check on the four standard NimbleGen internal controls. Successful enrichment of the capture libraries was estimated to range from a 6 to 9 of ΔCT value over the non-enriched samples.
Rokita J.L., Rathi K.S., Cardenas M.F., Upton K.A., Jayaseelan J., Cross K.L., Pfeil J., Egolf L.E., Way G.P., Farrel A., Kendsersky N.M., Patel K., Gaonkar K.S., Modi A., Berko E.R., Lopez G., Vaksman Z., Mayoh C., Nance J., McCoy K., Haber M., Evans K., McCalmont H., Bendak K., Böhm J.W., Marshall G.M., Tyrrell V., Kalletla K., Braun F.K., Qi L., Du Y., Zhang H., Lindsay H.B., Zhao S., Shu J., Baxter P., Morton C., Kurmashev D., Zheng S., Chen Y., Bowen J., Bryan A.C., Leraas K.M., Coppens S.E., Doddapaneni H., Momin Z., Zhang W., Sacks G.I., Hart L.S., Krytska K., Mosse Y.P., Gatto G.J., Sanchez Y., Greene C.S., Diskin S.J., Vaske O.M., Haussler D., Gastier-Foster J.M., E. Anders K., Gorlick R., Li X.N., Reynolds C.P., Kurmasheva R.T., Houghton P.J., Smith M.A., Lock R.B., Raman P., Wheeler D.A, & Maris J.M. (2019). Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. Cell reports, 29(6), 1675-1689.e9.
+ Open protocol
+ Expand
4

Exome Capture Workflow for FFPE, FF, and Normal Samples

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
For exome capture, FFPE, FF and normal samples were pooled separately as 4 libraries per pool using 250 ng of library for each sample. These pools of libraries were then hybridized separately in solution to the HGSC VCRome 2.1 design (Bainbridge et al., 2011 (link)) (42Mb, NimbleGen) according to the manufacturer’s protocol NimbleGen SeqCap EZ Exome Library SR User’s Guide (Version 2.2) form samples enriched between 2015-2017. Starting in December 2017, probes for exome coverage across >3,500 clinically relevant genes that are previously <20X (~2.72Mb) were supplemented with PKv1 and PKv2 into the VCRome 2.1 probe to enhance capture performance of low coverage regions. Blocking oligonucleotides from Sigma (individually sequence specifically synthesized) or xGen Universal Blocking oligonucleotides (Integrated DNA Technologies) were added into the hybridization to block the adaptor sequences. Hybridization for FF and normal samples was performed at 56°C for ~16h and for FFPE samples hybridization was at 42°C for 72h. Post-capture LM-PCR amplification was performed using the Library Amplification Readymix containing KAPA HiFi DNA Polymerase (Kapa Biosystems, Inc., Cat # KK2612) with 12 cycles of amplification. After the final AMPure XP bead purification, quantity and size of the capture library was analyzed using the Agilent Bioanalyzer 2100 DNA Chip 7500.
Wheeler D.A., Takebe N., Hinoue T., Hoadley K.A., Cardenas M.F., Hamilton A.M., Laird P.W., Wang L., Johnson A., Dewal N., Miller V., Piñeyro D., de Moura M.C., Esteller M., Shen H., Zenklusen J.C., Tarnuzzer R., McShane L.M., Tricoli J.V., Williams P.M., Lubensky I., O’Sullivan-Coyne G., Kohn E.C., Little R.F., White J., Malik S., Harris L., Weil C., Chen A.P., Karlovich C., Rodgers B., Shankar L., Jacobs P., Nolan T., Hu J., Muzny D.M., Doddapaneni H., Korchina V., Gastier-Foster J., Bowen J., Leraas K., Edmondson E.F., Doroshow J.H., Conley B.A., Ivy S.P, & Staudt L.M. (2020). Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment. Cancer cell, 39(1), 38-53.e7.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!